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CD4+ T cells are commonly classified as ‘helper’ T cells on the basis 
of their roles in providing help to promote or dampen cellular and 
humoral immune responses. In contrast, CD8αβ+ cytotoxic T lympho­
cytes (CTLs) provide direct protective immunity by killing infected 
or transformed cells. The helper T cell program is initially induced 
during thymic development, during which thymocytes expressing 
a major histocompatibility complex (MHC) class II–reactive T cell 
antigen receptor (TCR) develop into the CD4+ helper T cell lineage, 
whereas thymocytes with specificity for MHC class I differentiate into 
the CD8+ CTL lineage. The functional programming, which coincides 
with but does not depend on the MHC restriction or expression of the 
coreceptor CD4 or CD8αβ, is controlled by the action and counter­
action of key transcription factors. Together with Tox and GATA­3, the 
helper T cell transcription factor ThPOK (cKrox; encoded by Zbtb7b 
(called ‘Thpok’ here)) first induces the CD4+ helper T cell fate and 
prevents thymocytes from differentiating into CD8+ CTLs1–6. Runx3, 
a member of the Runx family of transcription factors, has the opposite 
effect and terminates CD4 expression while promoting differentiation 
into the CTL lineage7,8. The CD8­CD4 lineage dichotomy persists in 
the periphery for mature T cells, in which ThPOK continues to sup­
press the cytotoxic fate of MHC class II–restricted CD4+ T cells even 
as they differentiate into effector helper T cell subsets controlled by 
additional transcription factors6.
That lineage separation, however, is not all encompassing, and 
reports have repeatedly indicated the presence of CD4+ T cells 
with cytolytic functions in various species, including humans and 
rodents9–12. At steady state, populations of the effector cells that reside 
in the intestine as intraepithelial lymphocytes (IELs) show enrich­
ment for cytotoxic T cells, including CD4+ T cells13–15, whereas under 
inflammatory conditions, including viral infections, autoimmune dis­
orders and in response to tumor antigens, many cytolytic CD4+ T cell 
populations expand in the blood and peripheral tissues9–12,16,17. Their 
widespread abundance and participation in various beneficial as well 
as pathogenic adaptive immune responses9–12,16,17 underscore the 
physiological relevance of cytolytic CD4+ effector cells. However, the 
generation of convincing evidence directly linking them to specific 
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TCRab thymocytes differentiate into either CD8ab+ cytotoxic T lymphocytes or CD4+ helper T cells. This functional dichotomy 
is controlled by key transcription factors, including the helper T cell master regulator ThPOK, which suppresses the cytolytic 
program in major histocompatibility complex (MHC) class II–restricted CD4+ thymocytes. ThPOK continues to repress genes of 
the CD8 lineage in mature CD4+ T cells, even as they differentiate into effector helper T cell subsets. Here we found that the 
helper T cell fate was not fixed and that mature, antigen-stimulated CD4+ T cells terminated expression of the gene encoding 
ThPOK and reactivated genes of the CD8 lineage. This unexpected plasticity resulted in the post-thymic termination of the helper 
T cell program and the functional differentiation of distinct MHC class II–restricted CD4+ cytotoxic T lymphocytes.
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aspects of the adaptive immune response has been difficult, as they 
have been viewed merely as functional variants of the well­defined 
T helper type 1 (TH1) subtype12,18. The lack of a defined gene signa­
ture has also greatly impaired progress in elucidating the biology of 
cytolytic CD4+ T cells and in designing clinical strategies that specifi­
cally target these cells in various diseases.
Here we provide proof indicating that cytotoxic CD4+ T cells rep­
resent a distinct subset of effector cells that can be defined by the 
absence of the master regulator ThPOK, which maintains the helper 
T cell fate in all subsets of classical CD4+ helper T cells by continuously 
suppressing the CD8+ CTL lineage program6. Nevertheless, we also 
found that the ThPOK− CD4+ CTLs originated from ThPOK­expressing 
progenitor cells that initially committed to the ThPOK­controlled 
helper T cell lineage during thymic selection. Our findings therefore 
challenge the view that the helper T cell program in CD4+ T cells is 
fixed and show that mature CD4+ T cells can lose ThPOK expression 
post­thymically and can be functionally reprogrammed to become 
MHC class II–restricted CTLs. We also identify the Thpok silencer as 
the transcriptional switch that terminated Thpok transcription and by 
default drove the derepression of the CTL program in mature CD4+ 
effector cells. At steady state, CD4+ CTLs remained immunologically 
quiescent even in the continuous presence of their cognate antigens. 
However, in response to restimulation in the context of interleukin 15 
(IL­15), CD4+ CTLs greatly increased their inflammatory and cyto­
lytic functions and differentiated into potent killer effector cells. 
Overall, our data demonstrate that CD4+ CTLs are not a simple vari­
ant of classical ThPOK­controlled TH1 cells but instead are distinct 
functional MHC class II–restricted effector cells that can be char­
acterized by the loss of ThPOK expression and the derepression of 
aspects of the gene­expression program of the CD8+ CTL lineage.
RESULTS
Not all mature CD4+ T cells express ThPOK
The reported cytolytic activity of mature CD4+ T cells is inconsistent 
with the idea that ThPOK continuously suppresses the CTL program 
in all mature, MHC class II–restricted CD4+ T cells6 and suggests 
that these cells might not be under the negative control of ThPOK. 
To investigate this, we analyzed ThPOK expression in mature T cells 
isolated from reporter mice with sequence encoding green fluores­
cent protein (GFP) knocked in to the ThPOK locus (Thpok­GFP 
mice)19. As expected, CD4+ Thpok­GFP lymphocytes isolated from 
the spleen or mesenteric lymph nodes (mLNs), which are mostly naive 
T cells, were GFP+ (Fig. 1a), which indicated that they all expressed 
ThPOK, as is typical of mature cells of the CD4+ helper T cell line­
age. Conversely, all cells in the CD8+ fraction were GFP− (Fig. 1a), 
consistent with the absence of ThPOK expression in cells of the CTL 
lineage. Unexpectedly, many of the Thpok­GFP CD4+ effector T cells 
that accumulated in the intestine at steady state were GFP− (Fig. 1b,c), 
which indicated that like their CD8+ counterparts, they did not express 
ThPOK. Notably, most of the GFP− CD4+ cells were in the subset of 
double­positive (DP) IELs that coexpressed CD4 and CD8α without 
CD8β20 (Fig. 1b–d). Consistent with the lack of ThPOK­mediated 
suppression, these CD4+CD8α+CD8β− cells also had functional 
features similar to those of mature CD8+ CTLs, including abundant 
expression of granzyme (Fig. 1e,f) and substantial expression of the 
activation­induced degranulation marker CD107a (LAMP­1), a glyco­
protein present in the membrane of cytotoxic granules and exposed 
on the surface of activated cytolytic cells21 (Fig. 1g,h). The induction 
of CD107a by the DP subset was similar to that of typical TCRαβ+ 
CD8+ CTLs, whereas activated CD4+CD8α− single­positive (SP) IELs 



























































































































































































Figure 1 Some mature CD4+ T cells do not maintain ThPOK expression in the periphery. (a) Frequency of GFP+ cells (numbers above bracketed lines) 
among gated CD45+TCRβ+ lymphocytes isolated from the spleen and mLNs of naive Thpok-GFP reporter mice (n = 4 or 5). (b) Frequency of GFP+ cells 
(numbers above bracketed lines) among gated CD45+TCRβ+ IELs isolated from the small intestine (sIEL) of naive Thpok-GFP reporter mice (n = 4 or 5).  
(c) Cell surface staining for CD8α and GFP on gated CD45+TCRβ+CD8β−CD4+ IELs as in b. Numbers in quadrants indicate percent cells in each 
throughout. (d) Cell surface staining for CD8α and CD8β on gated CD45+TCRβ+CD4+ IELs as in b. (e) Cell surface staining for CD8α and intracellular for 
staining granzyme B (Gzmb) on or in gated CD45+TCRβ+CD8β−CD4+ lymphocytes isolated from the spleen and mLNs and IELs from the small intestine 
of naive wild-type C57BL/6 mice (n = 4 or 5). (f) Mean fluorescence intensity (MFI) of granzyme B in CD4+, CD4+CD8α+ or CD8αα+ T cells among gated 
CD45+TCRβ+CD8β− lymphocytes from the spleen and mLNs and IELs of naive wild type C57BL/6 mice (n = 4 or 5); results are presented relative to those 
of the CD4+CD8α+ subset, set as 100%. *P < 0.05 (analysis of variance (ANOVA) with Bonferroni’s post-test). (g) Frequency of CD107+ cells (number in 
outlined area at right) among total gated CD45+TCRβ+CD8β−CD4+ and CD45+TCRβ+CD8αβ+ IELs after stimulation with antibody to TCRβ. (h) Frequency of 
CD107+ cells among CD4+ splenocytes or TCRγδ+, CD8αα+, CD8αβ+, CD4+CD8α− and CD4+CD8α+ IEL subsets after stimulation with antibody to TCRβ  
(n = 4 replicates). *P = 0.02 (nonparametric two-tailed Mann-Whitney test). (i) Cytotoxicity of lymphocyte subsets, assessed by lactate dehydrogenase–
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(Fig. 1g,h). Moreover, activated DP cells also effectively killed target 
cells in vitro, as measured by the release of lactate dehydrogenase after 
lysis of target cells (Fig. 1i and Supplementary Fig. 1a). In sum, these 
data demonstrated that in normal mice, not all CD4+ effector cells 
expressed ThPOK and, furthermore, that those ThPOK− CD4+ lym­
phocytes expressed CD8α (but not CD8β) and had cytolytic activity 
that closely resembled that of mature CD8+ CTLs.
Mature ThPOK− CD4+ T cells derive from ThPOK+ thymocytes
ThPOK is the master regulator of the helper T cell lineage and is first 
expressed in the thymus, where it counteracts Runx3 and suppresses 
the CTL fate of MHC class II–restricted thymocytes4–6. The absence 
of ThPOK expression associated with cytotoxicity in mature CD4+ 
T cells could suggest that they might have originated from ThPOK− 
progenitors. To investigate this, we designed a fate­mapping mouse 
model in which we tracked previous ThPOK expression in mature 
T cell subsets (Fig. 2a). Inactivation of Thpok transcription in MHC 
class I–specific thymocytes of the CD8+ CTL lineage is mediated 
by repressive factors, such as Runx proteins, that bind to the Thpok 
silencer DNA element22,23. In MHC class II–restricted cells, however, 
ThPOK itself binds to the Thpok silencer and prevents Runx­mediated 
silencing, which results in a positive feedback loop with continuous 
expression of Thpok (Fig. 2a). A fate marker that reports any previous 
activity of the Thpok silencer in thymocytes is therefore an accurate 
reporter for the lineage origin and initial commitment of mature 
CD4+ T cells. On the basis of that rationale, we designed a mouse 
strain with transgenic expression of Cre recombinase, ‘ThPOK­Cre’, 
in which a Thpok silencer inserted into a Cd4 enhancer­promoter 
locus controls expression of a transgene encoding Cre (Fig. 2a). 
In contrast to the widely used strain of mice that express Cre under the 
control of the Cd4 enhancer­promoter starting at the CD4+CD8αβ+ 
thymocyte stage, in ThPOK­Cre mice, the Thpok silencer prevents 
Cd4 enhancer­promoter activity in immature thymocytes and cells of 
the CD8 lineage, which results in Cre expression exclusively in mature 
CD4+ SP thymocytes committed to the helper T cell lineage (Fig. 2a). 
Consistent with that, in progeny of a cross of ThPOK­Cre mice with 
reporter mice expressing yellow fluorescent protein (YFP) from the 
ubiquitous Rosa26 promoter (Rosa26­YFP), we found that only cells 
derived from thymocytes that were committed to the CD4+ helper 
T cell lineage were marked by the expression of the YFP reporter 
after Cre­mediated recombination (Fig. 2b,c). In those progeny of the 
Rosa26­YFP × ThPOK­Cre cross, CD8+ SP thymocytes and mature 
peripheral CD8+ T cells, including CD4−CD8+ mucosal T cells, did 
not express YFP, whereas, as expected, most CD4+ SP lymph node 
T cells and IELs were YFP+. Notably, CD8α­expressing CD4+ IELs 
were also YFP+, to an extent similar to that of conventional CD4+ 
SP cells (Fig. 2b,c), which indicated that they had induced ThPOK­
dependent Cre expression and therefore that the mature ThPOK− 
CD4+ T cells must have been derived from progenitor cells that 
expressed ThPOK at an earlier stage.
ThPOK+CD4+ helper T cells lose ThPOK expression
The idea that the mature ThPOK− CD4+ cells previously expressed 
ThPOK, together with the observation that those cells mainly accu­
mulated among effector cells, suggested that the loss of ThPOK 
expression might have been the result of a post­thymic activa­
tion or maturation process that mature T cells undergo in the 
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Figure 2 Mature ThPOK− CD4+ T cells are the progeny of ThPOK-expressing thymocytes. (a) Endogenous Thpok (left) and the transgene encoding 
ThPOK-Cre (right) in thymocytes of the CD8 and CD4 lineages. STH, Thpok silencer; PTH, Thpok promoter; E4P4, Cd4 enhancer-promoter; IRES, 
internal ribosomal entry site; CD2, human gene encoding CD2; PA, poly(A) tail. (b) Staining for CD8α and CD4 (middle) and for human CD2 (hCD2) 
and YFP (left and right) in thymocytes gated on expression of CD4 and CD8α (gates 1–6 (middle), where 1 represents immature DP thymocytes and 5 
and 6 represent mature CD4+ and CD8+ SP thymocytes, respectively), from Rosa26-YFP mice and Rosa26-YFP mice expressing ThPOK-Cre (with the 
transgene in a; Rosa26-YFP × ThPOK-Cre). Numbers above bracketed lines (left and right) indicate percent cells positive for human CD2 (ThPOK-Cre+; 
top rows) or YFP+ cells (bottom rows). (c) Staining for CD4 and CD8α (contour plots) and YFP (histograms) in cells from the peripheral lymph nodes 
(pLN) and IELs from the small intestine of mice as in b, gated on TCRβ+CD4+ lymphocytes. Numbers adjacent to outlined areas indicate percent cells 
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ThPOK­expressing GFP+ naive Thpok­GFP CD4+ T cells into recipi­
ent mice deficient in recombination­activating gene 1 (Rag1−/− mice). 
The lymphopenic conditions in this model induced strong prolifera­
tion and differentiation of the donor cells, which accumulated mainly 
as cells of the TH17 subset of helper T cells (characterized by the 
expression of the transcription factor RORγt and the cytokine IL­17) 
in the large intestine, and notably, also as DP effector cells, especially 
in the small intestine of the Rag1−/− hosts (Fig. 3a,b). Donor cells 
in the spleen and mLNs were GFP+ (Fig. 3c), which indicated that 
they continued to express ThPOK. In contrast, many of the Thpok­
GFP CD4+ T cells that accumulated as effector cells in the intestine 
did not have detectable expression of GFP (Fig. 3c), which indicated 
that they had substantially diminished or complete loss of ThPOK 
expression. Consistent with the observations obtained with immuno­
logically replete mice, the loss of GFP expression was again greatest 
in those CD4+ cells that also reinduced CD8α expression, although 
a small fraction of CD4+ SP IELs were also GFP− (Fig. 3c,d). Serial 
transfer of those SP donor cells into a second set of Rag1−/− recipi­
ents generated many more DP cells (Fig. 3e), which indicated that 
the reexpression of CD8α on mature CD4+ T cells followed the loss 
of ThPOK expression and further indicated that the Cd8a locus in 
conventional CD4+ helper T cells might be constitutively suppressed 
by ThPOK. To analyze this, we used chromatin immunoprecipitation 
(ChIP) combined with tiling arrays of cells from genetically engi­
neered mice that express Flag­hemagglutinin epitope–tagged ThPOK 
(FH­ThPOK) from the Thpok locus19. FH­ThPOK associated with 
the E8I enhancer element24 in the Cd8a locus in SP CD4+ thymo­
cytes (Fig. 3f). We also confirmed that result in mature CD4+ SP 
T cells by ChIP assay (Supplementary Fig. 2a), which suggested that 
in mature CD4+ thymocytes and lymphocytes, ThPOK prevented 
CD8α expression by direct suppression of the E8I enhancer element 
in the Cd8a locus, and also that the expression of CD8α without 
CD8β in mature ThPOK− CD4+ T cells was driven by derepression 
of the E8I enhancer. In support of that finding, both the frequency of 
CD8α­expressing CD4+ IELs and CD8 expression itself were much 
lower in E8I­deficient mice than in wild­type mice (Fig. 3g), a finding 
also true for the progeny of E8I­deficient cells versus wild type donor 
cells in Rag1−/− recipients of an equal number of both genotypes of 
donor cells (Fig. 3h and Supplementary Fig. 2b). Overall the data 
indicated that naive ThPOK+ CD4+ helper T cell cells might have lost 
expression of ThPOK in the periphery and consequently regained 
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Figure 3 ThPOK− CD4+ effector cells lost ThPOK as mature cells in the periphery. (a) Staining of CD8α and intracellular IL-17 in gated 
CD45+TCRβ+CD4+ IELs from the small intestine (sIEL) and large intestine (lIEL) of Rag1−/− recipient mice 8 weeks after adoptive transfer of naive 
CD45RBhiTCRβ+CD8α−CD25−CD4+ spleen T cells. (b) Staining of CD8α and CD4 in gated CD45+TCRβ+CD4+ T cells from the spleen and mLNs, 
lymphocytes from the lamina propria of the small intestine (sLPL) and large intestine (lLPL) and IELs from the small intestine and lage intestine of 
Rag1−/− recipient mice 8 weeks after adoptive transfer of naive CD45RBhiTCRβ+CD8α−CD25−CD4 spleen T cells. (c) Expression of Thpok-GFP in 
gated CD45+TCRβ+ CD4+ (SP) or CD4+CD8α+CD8β− (DP) lymphocytes isolated from various tissues (as in a,b) of Rag1−/− recipient mice 8 weeks after 
transfer of sorted CD45RBhiTCRβ+CD8α−CD25−CD4+ spleen T cells from Thpok-GFP donor mice. Numbers above bracketed lines indicate percent 
GFP+ cells (mean ± s.e.m.). (d) Frequency of GFP+ cells among gated CD45+TCRβ+ CD4+ (SP) or CD4+CD8α+CD8β− (DP) lymphocytes from spleen or 
mLNs or IELs of Rag1−/− recipients after transfer of sorted naive CD45RBhiTCRβ+CD8α−GFP+CD25−CD4+ spleen T cells from Thpok-GFP donor mice. 
*P < 0.001 (ANOVA and Bonferroni’s post-test). (e) Surface staining for CD8α on retransferred sorted (>99.7% purity) CD45+TCRβ+CD8α−CD4+ donor 
IELs isolated from mLNs (pooled from three recipient mice) and IELs of the small intestine another Rag1−/− recipient 8 weeks after the second transfer. 
Numbers adjacent to outlined areas indicate percent CD8α+ cells (mean ± s.e.m.). (f) ChIP with tiling array of CD4+ SP thymocytes from FH-ThPOK 
mice. I–V, Cd8 enhancers; green arrowhead indicates binding of ThPOK to the E8I region. (g) Frequency of CD8α+ cells (numbers adjacent to outlined 
areas) among CD45+TCRβ+CD8β−CD4+ IELs isolated from a wild-type mouse (WT) and an E8I-deficient mouse (E8I-KO). (h) Frequency of CD8α+CD4+ 
IELs from Rag1−/− recipient mice 8 weeks after transfer of wild type or E8I-deficient CD45RBhiTCRβ+CD8α−CD25−CD4+ spleen T cells. Each symbol 
represents an individual mouse; small horizontal lines indicate the mean. *P < 0.001 (ANOVA and Bonferroni’s post-test). Data are representative of 
three independent experiments (a–d; error bars (d), s.e.m.), two independent experiments (e,f,h) or three independent experiments with four or five 
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ThPOK loss coincides with CTL differentiation
Although subsets of polarized CD4+ effector cells are controlled by 
unique transcription factors, such as T­bet for TH1, GATA­3 for TH2 
and RORγt for TH17 cells, ThPOK continues to function as a mas­
ter regulator of the helper T cell lineage and continues to suppress 
the CTL program. Consistent with that, naive Thpok­GFP donor 
spleen cells that differentiated into TH17 effector cells in the intes­
tine of the Rag1−/− recipient mice remained GFP+ (Fig. 4a), which 
indicated that their gene­expression profile was still regulated by 
the ThPOK. To examine the effect of the loss of ThPOK expression 
on the gene­expression pattern of CD4+ effector cells, we analyzed 
gene microarrays generated from RNA isolated from sorted ThPOK+ 
or ThPOK− SP and DP effector cells from normal unmanipulated 
Thpok­GFP reporter mice19 (Fig. 4b) and from Rag1−/− recipients of 
naive Thpok­GFP CD4+ SP donor cells (Fig. 4c and Supplementary 
Fig. 3a). Notably, we found that DP and SP ThPOK− CD4+ T cells 
had a unique but similar gene­expression pattern that differed from 
that of SP ThPOK+ CD4+ cells, although in the transfer experiments, 
the donor cells originated from the same pool of naive lymphocytes 
and differentiated in the same host environment (Fig. 4b,c and 
Supplementary Fig. 3a). As expected, many of the ThPOK+ CD4+ SP 
cells isolated from the intestine had a distinct TH17 gene­expression 
pattern, whereas expression of those genes was barely detectable in the 
ThPOK− and DP subsets (Fig. 4b–d). Furthermore, RT­PCR analysis 
of genes characteristic of TH17 cells, including those encoding the 
cytokines IL­17A, IL­17F and IL­22, the cytokine receptor IL­23R 
and the TH17 hallmark nuclear transcription factor RORγt, con­
firmed that ThPOK− CD4+ effector cells were distinct from TH17 cells 
(Fig. 4e,f and Supplementary Fig. 3b). Moreover, analysis of genes 
characteristic of other CD4+ helper T cell types, such as TH1 and 
TH2 cells, demonstrated that the gene­expression pattern of CD4+ SP 
lymphocytes and DP lymphocytes that had lost ThPOK expression 
did not resemble the patterns of the known helper T cell effector 
subsets (Supplementary Fig. 3c).
In contrast, in addition to reexpressing CD8α, ThPOK− CD4+ 
 effector cells also expressed many other genes typically associated with 
the CD8+ CTL program. This included the expression of various genes 
encoding cytolytic proteins, such as several granzymes and perforin, as 
well as interferon­γ (IFN­γ) and several receptors expressed by natural 
killer cells and mature CD8+ CTLs (Fig. 4b,c,g,h and Supplementary 
Fig. 3d,e). Of particular note was their expression of the cytotoxicity­
related, MHC class I–restricted, T cell–associated molecule CRTAM 
and the CD2 family member CD244 (2B4), both known to promote the 
cytolytic function and IFN­γ production of CD8+ T cells25–27.
The reciprocal expression in mature CD4+ effector cells of either 
ThPOK or CTL signature genes (Fig. 4i) confirmed the hypothesis 
that ThPOK continuously suppressed the CTL program in conven­




















































































































































































































































































































































































































Figure 4 Activated CD4+ helper T cells that lose ThPOK expression differentiate into CTLs. (a) Intracellular staining for IL-17 and GFP in gated 
CD45+TCRβ+CD4+ IELs from Rag1−/− recipients of sorted naive CD45RBhiTCRβ+CD8α−GFP+CD25−CD4+ spleen T cells from Thpok-GFP donor 
mice, assessed 8 weeks after cell transfer. (b) Gene-expression microarray analysis of mRNA from sorted CD45+TCRβ+ ThPOK+CD8α−CD4+, 
ThPOK−CD8α−CD4+ and ThPOK−CD8α+CD4+ IELs from naive Thpok-GFP reporter mice; results are relative to the change in expression in the 
ThPOK+CD4+CD8α− subset. (c) Gene-expression microarray analysis of mRNA from sorted CD45+TCRβ+ ThPOK+CD8α−CD4+, ThPOK−CD8α−CD4+  
and ThPOK−CD8α+CD4+ IELs from Rag1−/− recipients of sorted naive TCRβ+CD8α−GFP+CD45RBhiCD25−CD4+ spleen T cells from Thpok-GFP donor 
mice (presented as in b). (d) Heat map of normalized expression of TH17 signature genes in donor CD4+ T cells as in c, determined by microarray 
analysis as in b. (e,f) Quantitative real-time PCR analysis of mRNA from TH17-associated genes in sorted T cell subsets as in c (e) or d (f); results are  
presented relative to those for Rpl32. (g,h) Quantitative real-time PCR analysis of mRNA from CTL-associated genes in sorted T cell subsets as in c (g)  
or d (h), presented as in e,f. (i) Expression of ThPOK-GFP and 2B4 in gated CD45+TCRβ+CD4+ IELs as in a (left), and quantitative real-time PCR 
analysis of mRNA encoding CD8α, granzyme B, CRTAM and ThPOK in IELs sorted for (CD45+TCRβ+CD4+) GFP+, GFP−CD8α− and GFP−CD8α+ subsets 
isolated from Rag1−/− recipients as in a (n = 4; right). (j) Staining for CD4 and CD8α (left and middle) and 2B4 (right) in gated TCRβ+CD4+ IELs from 
Rag1−/− recipients (n = 3) of untransfected (GFP−) or ThPOK-transfected (GFP+) TCRβ+CD8α−CD45RBhiCD25−CD4+ donor spleen T cells. Data are 
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of CD4+ CTL effector cells coincided with the post­thymic loss of 
ThPOK. In agreement with that, after enforced expression of ThPOK 
via retroviral transduction, CD4+ donor cells no longer differentiated 
into CTLs in vivo (Fig. 4j), whereas transfection of a construct encod­
ing Thpok with a spontaneous mutation found in the helper­deficient 
mouse strain4 did not prevent the differentiation of helper T cells into 
CD4+ CTLs (Supplementary Fig. 3f). These data indicated that the 
loss of ThPOK coincided with derepression of the CTL phenotype in 
mature CD4+ effector cells.
Thpok silencer derepression terminates Thpok expression
In thymocytes committed to the CD8+ CTL lineage, ThPOK expres­
sion is switched off at the transcriptional level by the Thpok silencer22. 
Consequently, in mice with germline deletion of this silencer 
(ThpokS∆/S∆ mice), MHC class I–restricted thymocytes mature as 
CD4­expressing T cells in the periphery22. To determine if the Thpok 
silencer engages in a similar role to terminate Thpok expression in 
mature MHC class II–restricted precursors of CD4+ CTLs, we ana­
lyzed the peripheral maturation of CD4+ T cells in ThpokS∆/S∆ mice. 
To eliminate the MHC class I–restricted CD4­expressing cells in these 
mice, we crossed the ThpokS∆/S∆ mice with MHC class I–deficient 
(β2­microglobulin­deficient (B2m−/−)) mice, which abrogated the 
development of MHC class I–restricted CD4+CD8+ T cells. Notably, 
we found considerable enhancement of all CD4+ populations, includ­
ing DP IELs, in B2m−/− mice, in the absence of mature CD8+ T cells 
(Fig. 5a); however, ThpokS∆/S∆B2m−/− mice had considerably fewer 
mature MHC class II–restricted CD8α­expressing CD4+ T cells 
(Fig. 5a). These observations indicated that the Thpok silencer was a 
critical genomic switch in the process of the differentiation of CD4+ 
CTLs that turned off Thpok transcription in mature CD4+ T cells. We 
further confirmed that idea with CD4+ T cells in which a loxP­flanked 
Thpok silencer (ThpokSfl/Sfl) was deleted at the mature stage by trans­
fection of the cells with a retroviral construct containing sequence 
encoding Cre linked to GFP. The transfer of transfected ThpokSfl/Sfl 
CD4+ T cells (which expressed Cre (GFP+) and consequently had 
deletion of the Thpok silencer) into Rag1−/− recipient mice resulted 
in impaired accumulation of CD8α­expressing CD4+ CTLs in the 
intestine of the recipients (Fig. 5b), which further emphasized the 
critical role of the Thpok silencer in terminating Thpok expression as 
part of the CTL­differentiation process of CD4+ effector cells. In con­
trast to ThPOK, which suppresses the repressive activity of the Thpok 
silencer, the zinc­finger transcription factor MAZR is known to acti­
vate the Thpok silencer28, which results in MAZR­induced negative 
regulation of Thpok transcription. Consistent with the participation 
of MAZR in reactivation of the Thpok silencer in mature CD4 T cells, 
MAZR­deficient CD4+ donor cells transferred into Rag1−/− recipi­
ent mice formed fewer CD8α­expressing CD4+ CTLs than did their 
wild­type counterparts in the intestine of the recipients (Fig. 5c,d). 
These results indicated that transcriptional regulation of Thpok was 
key for control of the helper T cell phenotype of mature CD4+ T cells 
and that reactivation of its silencer led to termination of the helper 
T cell program and, conversely, to the functional differentiation of 
MHC class II–restricted CD4+ CTLs.
CD4+ CTL differentiation is driven in vivo by antigen
The loss of ThPOK observed in progeny of naive ThPOK+ donor cells 
suggested that induction of the CTL program in mature CD4+ T cells 
coincided with an activation or maturation process. The reexpression 
of CD8α as well as the cytolytic functional differentiation of mature 
CD4+ T cells was reminiscent of the cytotoxic­lineage differentiation 
of positively selected CD8+ SP thymocytes mediated by IL­7 (ref. 29). 
Despite that, however, we found significantly more CD8α­expressing 
CD4+ CTLs in mice deficient in the receptor for IL­7 than in wild­
type mice (Fig. 6a), which indicated that the in vivo differentiation of 
mature CD4+ CTLs was not an IL­7­driven process. Similar to other 
effector cells in the intestine, DP cells were not present in germ­free 
mice (Supplementary Fig. 4a) and seemed to be present in normal 
numbers in germ­free mice reconstituted with specific pathogen–free 
microorganisms (Supplementary Fig. 4b), which indicated that some 
microbial factors directly or indirectly promoted the accumulation 
of CD4+ CTLs in the intestine. In contrast, unlike classic CD4+ TH17 





















































































































Figure 5 The Thpok silencer forms the switch that  
terminates Thpok expression in mature CD4+ T cells.  
(a) Staining for CD8α and CD4 on gated TCRβ+CD4+  
IELs isolated from the small intestine of naive wild type, B2m−/− and  
ThpokS∆/S∆B2m−/− mice (left; n = 2 or 3 mice per genotype). Right, frequency  
of CD8α+CD4+ cells among those TCRβ+CD4+ IELs (each symbol represents  
an individual mouse; small horizontal lines indicate the mean). *P < 0.0001  
(two-tailed unpaired t-test). (b) Staining as in a of IELs isolated from the small  
intestine of Rag1−/− recipients 4–5 weeks after adoptive transfer of ThpokSfl/Sfl  
TCRβ+CD4+ cells transfected with an empty retroviral vector encoding GFP  
alone (EV) or retroviral vector encoding Cre-GFP (Cre), with gating on GFP+ or  
GFP− cells (left). Right, frequency of CD4+CD8α+ cells among those  
TCRβ+CD4+ IELs (presented as in a). (c) Staining for CD8α and GFP on IELs  
isolated from the small intestine of Rag1−/− recipients after transfer of sorted  
naive TCRβ+CD8α−GFP+CD45RBhiCD25−CD4+ spleen T cells from wild-type donor mice (WT) or MAZR-deficient Thpok-GFP  
donor mice (MAZR-KO), gated as in a. (d) Frequency of CD8α+GFP−CD4+ IELs as in c (presented as in a). *P = 0.03 (two-tailed  
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germ­free mice monocolonized with segmented filamentous bacteria 
alone30 (Supplementary Fig. 4b) or in response to an infection with 
Citrobacter rodentium, a pathogen known to induce a strong TH17 
response in the large intestine (Supplementary Fig. 4c), whereas they 
were present in normal numbers in the intestine of mice deficient in 
the adaptor MyD88. These observations indicated that the microbial 
conditions required for the steady­state accumulation of CD4+ CTLs 
in the intestine were probably not established by a single microorgan­
ism and did not depend on IL­1 signals or signals induced by Toll­like 
receptors (Supplementary Fig. 4d). Published reports have indicated 
that CD4+ CTLs are antigen­experienced cells that differentiate in 
response to repeated activation signals10,12. In agreement with that, DP 
cells with a CTL phenotype isolated from Rag1−/− recipients of naive 
spleen CD4+ SP T cells also showed evidence of strong or repeated 
activation and considerable uptake of the thymidine analog BrdU 
but only weak staining for the active cell­cycle marker Ki67 (Fig. 6b), 
which indicated that they were resting cells that had previously been 
activated and had previously intensely proliferated. In addition, CD4+ 
CTLs also had higher expression of the activation marker CD69 than 
did CD4+ SP effector helper T cells (Fig. 6b), which suggested that the 
activation process that coincided with the loss of ThPOK expression 
and derepression of the CTL program also coincided with those CD4+ 
effector cells that received strong or repeated activation signals. To 
directly investigate that, we analyzed the effector differentiation of 
monoclonal OT­II CD4+ T cells (which have transgenic expression of 
a TCR specific for ovalbumin amino acids 323–339 (OVA(323–339)) 
in response to continuous activation in vivo with their cognate peptide 
OVA(323–339) presented by I­Ab. T cells migrate as effector cells only 
to peripheral tissues, and in agreement with that, in the absence of 
OVA antigen, very few OT­II CD4+ T cells accumulated in the intes­
tine of OT­II mice. Similarly, after transfer of naive OT­II CD4+ T cells 
into Rag1−/− recipient mice, only a limited number of the donor cells 
migrated to the intestine of the recipient mice in the absence of OVA 
antigen (data not shown). In contrast, after mice were fed an OVA­
containing diet for at least 4 weeks, a large number of activated OT­II 
CD4+ cells accumulated in the intestine of the OT­II mice and the 
Rag1−/− recipients, and, notably, many reexpressed CD8α (Fig. 6c), 
whereas those that remained SP had a tendency to express the tran­
scription factor Foxp3 (Fig. 6c). To determine if the derepression of 
CD8α expression on the responder OT­II CD4+ T cells coincided 
with the loss of ThPOK and their differentiation into CTLs, we iso­
lated cells from OT­II Thpok­GFP reporter mice, transferred those 
naive donor cells into OVA­fed Rag1−/− recipient mice and analyzed 
the phenotype and function of the OVA­responding cells that accu­
mulated as effector cells in the intestine of the hosts. As expected, 
many OT­II Thpok­GFP DP cells accumulated in the small intes­
tine but, notably, they were all GFP− (Fig. 6d), which indicated that 
they had lost ThPOK expression. Furthermore, in addition to the 
reexpression of CD8α, OT­II GFP− effector cells also newly induced 
the expression of typical cytolytic markers, such as 2B4 and granzyme B 
(Supplementary Fig. 5a). Notably, they had an antigen­specific 
cytolytic response when restimulated in vitro with the OT­II TCR–
specific peptide OVA(323–339) (Fig. 6e) but not when restimulated 
with the MHC class I–restricted OVA peptide SIINFEKL (amino acids 
257–264; Supplementary Fig. 5b).
Despite their functional potential, OT­II ThPOK− CD4+ CTLs 
remained immunologically quiescent in vivo even in the continuous 
presence of their cognate antigen in the diet. That finding was simi­
lar to results obtained with MHC class I–restricted CD8αβ+ CTLs, 
which also seem to be inactive under steady­state conditions31. After 
challenge with excess amounts of IL­15, however, as in active celiac 
disease18,32, CD8+ CTLs become pathogenic killer cells33,34 that also 
considerably upregulate secretion of the inflammatory cytokines IFN­γ 
and tumor­necrosis factor (TNF)18,35,36,. To determine if CD4+ CTLs 
might be as responsive to IL­15 as CD8+ CTLs, we restimulated the 
diet­induced OT­II ThPOK− CD4+ CTLs in vitro in the context of 
IL­15. As expected, the addition of IL­15 resulted in higher CD8α 
expression37; however, IL­15 alone or together with the irrelevant 
MHC class I–restricted peptide SIINFEKL had no effect on the func­
tional differentiation or maturation of the MHC class II–restricted 
OT­II CD4+ CTLs (Supplementary Fig. 5b). In contrast, the addi­
tion of IL­15 resulted in considerably enhanced immune responses 
of OVA(323–339)­stimulated OT­II ThPOK− CD4+ CTLs, as mea­
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Figure 6 The ThPOK loss and reprogramming of CD4+ CTLs is an antigen-driven process in vivo. (a) Frequency of CD4+CD8α+ T cells among gated 
CD45+TCRβ+CD4+CD8β− IELs from wild-type mice or mice deficient in the receptor for IL-7 (Il7ra−/−). Each symbol represents an individual mouse; 
small horizontal lines indicate the mean. *P = 0.03 (nonparametric two-tailed Mann-Whitney test). (b) BrdU staining of IELs from the small intestine of 
naive wild type mice after intraperitoneal injection of 1 mg BrdU, followed by 6 d of BrdU (0.8 mg/ml) in the drinking water (left), and staining for Ki67 
(middle) and CD69 (right) of CD8α+ or CD8α− gated CD45+TCRβ+CD8β−CD4+ IELs from naive wild-type mice. (c) Staining for CD8α and Foxp3 in gated 
CD45+TCRβ+CD8β−CD4+ IELs (top) and lymphocytes from the lamia propria (bottom) of OT-II Rag1−/− mice (n = 4) after 4 weeks on an OVA-containing 
diet. (d) Frequency of CD8α+ and GFP+ cells among CD45+TCRβ+ CD4+ OT-II Thpok-GFP IELs isolated from Rag1−/− recipient mice after 4 weeks on 
an OVA-containing diet. (e) Frequency of CD107+, IFN-γ+ and TNF+ cells among OT-II Thpok-GFP ThPOK− or ThPOK+ CD45+TCRβ+ CD4+ IELs as in d, 
analyzed at day 0 without IL-15 exposure (0) or after 3 d of in vitro culture with recombinant IL-15 (3) before restimulation with OVA(323–339).  
(f) Frequency of CD107+, IFN-γ+ and TNF+ cells among wild-type CD8α+ and CD8α− CD45+TCRβ+CD8β−CD4+ polyclonal IELs cultured without or with 
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much greater production of IFN­γ and TNF (Fig. 6e). These data 
therefore demonstrated that antigen­induced CD4+ CTLs generated 
in the absence of inflammation were poised to exert potent effector 
functions when reactivated by their cognate antigen in the context 
of the inflammatory cytokine IL­15. We confirmed those data with 
polyclonal ThPOK− CD4+ CTLs isolated from the intestine of normal 
lymphocyte­sufficient mice and showed that unmanipulated CD4+ 
CTLs analyzed ex vivo also had the potential in response to polyclonal 
activation and to increase their cytolytic and inflammatory immune 
responses when exposed to IL­15. Although IL­15 alone supported 
short­term survival of wild­type CD4+ CTLs and CD8αβ+ CTLs, this 
cytokine alone did not induce cytolytic effector functions in these 
polyclonal cells (Supplementary Fig. 5c). In contrast, similar to 
results obtained with the dietary antigen–induced OT­II ThPOK− 
CD4+ CTLs or normal CD8αβ+ CTLs (Supplementary Fig. 5d), the 
addition of IL­15 also resulted in considerably enhanced cytolytic 
and inflammatory functions of wild­type polyclonal TCR­stimulated 
CD4+ CTLs, whereas it had only a negligible effect on ThPOK+ CD4+ 
helper T cells (Fig. 6f). These data emphasizes the likely pathogenic 
potential of antigen­induced ThPOK− CD4+ CTLs, which were poised 
to kill under conditions in which IL­15 was abundant.
DISCUSSION
The results reported here have indicated an unexpectedly large degree 
of plasticity for CD4+ helper T cells and have demonstrated that in 
response to chronic or strong stimulation with antigen, mature CD4+ 
cells were able to terminate their expression of the helper T cell mas­
ter regulator ThPOK (the signature transcription factor of the CD4 
lineage) and differentiate into functional CTLs. The identification 
of additional functional CD4+ T lymphocyte subsets defined by sig­
nature transcription factors, such as TH17 cells and Foxp3+ regula­
tory T cells, has been an important advance in immunology research. 
Although cytotoxic activity of CD4+ T cells has long been known, here 
we have shown that this was not simply a function of TH1­like cells. 
Instead, here we identified a previously unknown type of mature, antigen­ 
experienced CD4+ T cell characterized by the activation­induced 
loss of ThPOK. These cells had the concomitant appearance of a cell­
surface and functional phenotype that was distinct from that of con­
ventional helper T cell subsets but resembled that of CD8+ effector 
CTLs. Our data therefore indicate that the ThPOK­driven commit­
ment to the CD4+ helper T cell lineage is not fixed and that plasticity 
controlled at the level of ThPOK expression may lead to the functional 
differentiation of defined ThPOK− MHC class II–restricted CD4+ 
CTLs, despite their initial ThPOK expression and commitment to the 
helper T cell lineage or the MHC class II restriction of their TCRs.
The differentiation of CD4+ T lymphocytes into CTLs instead of 
their suppression and prevention from becoming inflammatory TH1 
or TH17 cells makes teleological sense at epithelial interfaces, where 
rapid elimination of infected cells is important not only for resistance 
to the initial invasion of intracellular pathogens but also for limiting 
or preventing excessive infiltration of systemically activated cytokine 
secreting cells that could jeopardize the integrity of the mucosal bar­
rier38. In addition, the cytotoxic function of the CD4+ CTLs may also 
contribute to diminishing infection and inflammation by eliminating 
infected migratory dendritic cells that could further prime naive cells 
or mediate systemic spread of the pathogen.
The MHC class II restriction of CD4+ CTLs might render these 
lymphocytes able to restrain viral infections tropic for MHC class II– 
positive target cells, including infected MHC class II–positive epi­
thelial cells39, Epstein­Barr virus–transformed B cells40 or human 
immunodeficiency virus–infected human CD4+ T cells41. Such T cells 
might also be critical for protection against viruses, including human 
immunodeficiency virus and cytomegalovirus, that have developed 
mechanisms to escape surveillance by MHC class I–restricted CD8+ 
CTLs40,42 or under conditions in which the control response of CD8+ 
CTLs becomes exhausted, as is the case in many chronic infections. 
In addition, as with CD8αβ+ CTLs, the responsiveness of CD4+ 
CTLs to IL­15 might provide a means for promoting their antigen­
specific or bystander protective ability against a variety of patho­
gens or for enhancing the efficacy of antitumor therapies involving 
adoptive cells.
It is also possible, however, that in inflammatory disorders that 
involve IL­15, such as celiac disease or virus­induced inflammatory 
conditions32,43, CD4+ CTLs may increasingly become pathogenic 
effector cells that harmfully destroy their target tissue and recruit 
other cell types of the immune system, thereby contributing to inflam­
matory pathogenesis. In the context of celiac disease, it has been dif­
ficult to connect the known pathogenic factors, including dietary 
antigens, association with MHC class II, IL­15 and TCR­depend­
ent and TCR­independent killer cells18,36. Our finding that dietary 
antigen–induced, MHC class II–restricted CD4+ CTLs became 
potent cytotoxic effector cells, producing large amounts of IFN­γ 
and TNF, when stimulated by their cognate antigen in the presence 
of IL­15 may form the long­sought ‘missing link’ that ties together 
the genetic and environmental factors involved in the pathogenesis 
of celiac disease.
In summary, the results presented here have identified CD4+ 
CTLs as distinct CD4+ effector cells defined by their post­thymic 
loss of ThPOK and the reciprocal functional differentiation of these 
MHC class II–restricted T lymphocytes into CTLs. Our data have 
also identified the Thpok silencer as the molecular switch that drives 
the unique post­thymic reprogramming of these CD4+ effector cells. 
The unexpected plasticity of mature CD4+ T cells in differentiating 
into CTLs expands the functional ability of MHC class II–restricted 
CD4+ effector cells to also include direct protective functions and 
provides the immune system with an alternative protective mecha­
nism, although the findings here have also demonstrated that these 
CD4+ CTLs may be central in driving the immunological pathology 
associated with inflammatory MHC class II–restricted T cells.
CD4+ effector cells with cytolytic functions have been known for 
a long time, and they have frequently been associated with beneficial 
as well as pathological immune responses. Nevertheless, progress in 
directly linking such cells to those events or targeting them as part 
of an immunological therapy has been extremely difficult mainly 
because they could not be separated from classic effector helper 
T cells. Therefore, the new insights reported here defining CD4+ CTLs 
as a distinct subset of effector cells and identifying the mechanism 
that leads to the unique differentiation of these cells provide informa­
tion to finally move forward the field of CD4+ CTLs and to specifically 
target these cells to enhance protective immunity or to prevent or treat 
inflammatory diseases and immunological pathology.
METHODS
Methods and any associated references are available in the online 
version of the paper.
Accession codes. GEO: microarray data, GSE41257 and GSE42277.
Note: Supplementary information is available in the online version of the paper.
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Mice. C57BL/6 CD45.1+ (Ly5.1+) and CD45.2+ (Ly5.2+) mice, OT­II 
mice, Rag1−/− mice and mice deficient in the receptor for IL­7 (all on a 
C57BL/6 background) were from The Jackson Laboratories, and CD4­Cre 
and C57BL/6 mice were from Taconic Farms. Swiss­Webster and C57BL/6 
germ­free and conventionally raised specific pathogen–free mice were 
from Taconic Farms or the University of North Carolina Gnotobiotic Core, 
respectively. Germ­free IQI mice were from Japan CLEA. Mice monocolo­
nized with segmented filamentous bacteria have been described44. Thpok­
GFP mice, ThpokS∆/S∆ mice and FH­ThPOK mice have been described19,22. 
OT­II Thpok­GFP mice were generated by the breeding of OT­II mice with 
Thpok­GFP reporter mice. ThpokS∆/S∆ mice were crossed with B2m−/− mice 
(The Jackson Laboratories) to obtain ThpokS∆/S∆B2m−/− mice. ThpokSfl/Sfl 
mice were generated in the Tanuichi laboratory (I.T., unpublished data). 
Sequences 826 base pairs in length that included the core Thpok silencer 
were flanked by two loxP sites in the Thpok allele. E8I­deficient mice were 
provided by D. Littman. MAZR­deficient mice were generated as described28 
and were crossed with Thpok­GFP mice. To generate mice with transgenic 
expression of Cre specifically in the CD4 lineage (ThPOK­Cre mice), we 
inserted a 562–base pair fragment of the Thpok silencer into a mini­transgene 
containing the minimal Cd4 enhancer­promoter. To target transgene expres­
sion, we inserted sequence encoding an internal ribosomal entry site and 
human CD2 downstream of the cDNA cassette encoding Cre. Mice were 
maintained at the La Jolla Institute for Allergy and Immunology vivar­
ium under specific pathogen–free conditions, and ‘sentinel mice’ from the 
Rag1−/− mouse colony were tested to be negative for Helicobacter species and 
C. rodentium. Animal care and experimentation were consistent with the 
guidelines of the US National Institutes of Health and were approved by 
the institutional Animal Care and Use Committees of the La Jolla Institute 
for Allergy and Immunology, the RIKEN Research Center for Allergy and 
Immunology, the Department of Immunology, Graduate School of Medicine, 
University of Tokyo and the Medical University of Vienna.
Antibodies and flow cytometry. The following antibodies were used: anti­
body to CD4 (anti­CD4; RM4­5), anti­CD25 (PC61), anti­CD44 (IM7), anti­
CD69 (H1.2F3), anti­CD107a (1D4B), anti­CD107b (ABL­93), anti­Vβ5.1 
and anti­Vβ5.2 (MR9­4), anti­CD244.2 (2B4) anti­Ki67 (B56) and anti­IFN­γ 
(XMG1.2; all from BD Biosciences); anti­TCRβ (H57­597), anti­TCRγδ 
(eBioGL3), anti­FoxP3 (FJK­16s) and anti­TNF (MP6­XT22; all from eBio­
science); anti­CD8α (53­6.7), anti­CD8β (YTS156.7.7), anti­CD45.2 (104), 
anti­Vα2 (B20.1) and anti­IL17A (TC11­18H10.1; all from Biolegend); and 
anti­CD8α (5H10) and anti–granzyme B (GB11; both from Invitrogen). 
Those antibodies were conjugated to the following fluorescent dyes: fluo­
rescein isothiocyanate, phycoerythrin, peridinin chlorophyll protein– 
cyanine 5.5, allophycocyanin, allophycocyanin–efluor 780, Alexa Fluor 700, 
Pacific blue, phycoerythrin­indotricarbocyanine, phycoerythrin–Texas Red 
and Horizon V500. Antibody to mouse CD16­CD32 used for blocking Fc 
receptors was produced in the Cheroutre laboratory. In some experiments, 
a LIVE/DEAD Fixable Yellow Dead Cell Stain Kit (Invitogen) was used for 
analysis of only live cell events. Flow cytometry data were acquired on an 
LSR II (Becton Dickinson) and were analyzed with FlowJo software (TreeStar). 
Doublets were excluded by forward­scatter area versus forward­scatter width 
and side­scatter area versus side­scatter width. A Foxp3 Mouse Regulatory 
T cell Staining Kit (eBioscience) was used for intracellular staining of Foxp3 
and granzyme B. For flow cytometry cytokine­secreting cells, cell popula­
tions were first stained with antibodies to cell surface markers, followed by 
permeabilization in Fix/Perm buffer and intracellular staining in Perm/Wash 
buffer (BD Pharmingen).
Preparation of IELs and lamina propria lymphocytes. IELs and lamina 
propria lymphocytes were isolated as described45.
Culture of IELs. IELs enriched by anti­CD45 microbeads (Miltenyi Biotec) 
or sorted on a FACSAria were cultured in RPMI medium in the presence of 
recombinant mouse IL­2 (BD Biosciences) and recombinant human IL­15 
(R&D Systems) at 37 °C with 5% CO2.
Cohousing and microbiota reconstitution. Cohousing and microbiota 
reconstitutions were done as described30.
Bacterial infection of mice. Wild­type C. rodentium strain DBS100 rendered 
resistant to chloramphenicol was obtained and used in all studies46. Bacteria 
were grown overnight in 3 ml Luria­Bertani broth with shaking at 37 °C, and 
bacterial titers were measured after each experiment by serial dilution. Mice 
were infected by oral gavage with 0.5 × 109 to 1.5 × 109 colony­forming units 
of C. rodentium (depending on experiment settings) and were killed at 14 d 
after infection.
Microarray and quantitative RT–PCR. RNA was prepared from sorted IEL 
populations with a FACSAria (Becton Dickinson). For microarray analysis, 
RNA was labeled and hybridized to GeneChip Mouse Genome 430 2.0 arrays 
according to Affymetrix protocols. Data were analyzed in GeneSpring GX10. 
RNA samples extracted with TRIZol (Invitrogen) with an iScript cDNA 
Synthesis kit (BIO­RAD) were used for cDNA synthesis. Real­time RT­PCR 
was done with the Roche 480 real­time PCR system. Values were normal­
ized by the amount of the gene encoding the ribosomal protein L32 in each 
sample. Primer sequences are listed below. For Illumina microarray analysis, 
RNA was labeled and hybridized to Illumina MouseRef­8 v2.0 Expression 
BeadChips array according to the Illumina protocols. Data were analyzed 
with GeneSpring gene­expression analysis software (version 12.2). The heat 
maps were generated with the heatmap.2 function of R language. The inputs 
are log2­transformed, normalized microarray probe­set intensities. For genes 
with multiple probe sets on the array, average intensities were used to pro­
duce the heat map. Normalized values were used for unsupervised analysis 
with GeneSpring and analysis of gene ontology with IPA software (ingenuity 
pathway analysis). This analysis showed that the main changes were related to 
genes encoding molecules involved in T cell differentiation and activation. On 
the basis of those data, a supervised analysis of clusters of genes (or families) 
that most represented differences between the groups was made and presented. 
The full data sets were submitted to the GeoArchive database.
Adoptive-transfer model. Sorted naive (CD4+CD45RBhi) T cells (5 × 105) were 
transferred into Rag1−/− mice, as described45. The purity of sorted naive cells 
was >99.7% and was usually >99.9%. At 4–8 weeks after transfer, donor cells 
were isolated from various tissues of the Rag1−/− recipient mice and analyzed.
Generation of dietary antigen–induced OT-II CD4+ IELs. For isolation of 
naive OT­II Thpok­GFP+ CD4+ cells, splenocyte samples were enriched for 
CD4+ cells by positive selection with anti­CD4 microbeads according to the 
manufacturer’s instructions (Miltenyi Biotec), followed by sorting for CD44lo 
CD62LhiVα2+Vβ5+Thpok­GFP+ CD4+ cells with a FACSAria. Naive OT­II 
Thpok­GFP+ CD4+ cells (1 × 106) were transferred into the Rag1−/− recipients 
by the retro­orbital route. For the activation of antigen­specific OT­II T cells, 
those Rag1−/− recipients were fed an ovalbumin­containing diet for 4 weeks.
ChIP and tiling array. ChIP plus micrarray was done as described19. Chromatin 
DNA isolated from CD4+ SP thymocytes (10 × 106) from FH­ThPOK mice 
was immunoprecipitated with anti­Flag (M2; Sigma­Aldrich), followed by two 
rounds of amplification by ligation­mediated PCR according to the manufac­
turer’s protocol (Agilent). Custom microarrays generated by Agilent that tiled 
through the mouse Cd8 locus by means of 60­nucleotide probes were used. 
Probe hybridization and scanning of oligonucleotide array data were done 
according to manufacturer’s protocol (Agilent). Feature Extraction software 
and ChIP Analytics software (Agilent) were used for data analysis.
ChIP. Cells were fixed for 10 min with a 10% formaldehyde solution, fol­
lowed by cell lysis and sonication to solubilize and shear crosslinked 
chromatin DNA. The resulting whole­cell extracts were incubated with 
anti–mouse immunoglobulin beads or anti–rabbit immunoglobu­
lin beads (Invitrogen) and the appropriate antibody, then samples were 
washed and bound complexes were eluted from the beads. The primers 
used were as follows: E8I forward, 5′­CAATGCGAATGTGACTCAAG­3′, 





























forward, 5′­TGGTTTCGAGACTGGCTGGT­3′, and Thpok silencer reverse, 
5′­GACCGAGGAGCTGCTTTCAG­3′.
Retroviral transduction of CD4 T cells. Primary CD4+ T cells were trans­
duced with retroviral vectors containing Thpok, Thpok with the spontaneous 
mutation found in the helper­deficient mouse strain, or sequence encoding 
Cre as described47. Thpok vectors were a gift from D. Kappes. Transfected cells 
were purified with a FACSAria, and 1 × 106 to 2 × 106 cells were transferred 
into Rag1−/− mice. Then, 4–5 weeks after transfer, tissues were recovered from 
recipient mice for flow cytometry.
Primers for quantitative PCR. These primers were as follows: GATA­3 
forward, 5′­AGGATGTCCCTGCTCTCCTT­3′, and GATA­3 reverse, 5′­GCCT 
GCGGACTCTACCATAA­3′; ThPOK forward, 5′­ATGGGATTCCAAT 
CAGGTCA­3′, ThPOK reverse, 5′­TTCTTCCTACACCCTGTGCC­3′; 
T­bet forward, 5′­ATCCTGTAATGGCTTGTGGG­3′, and T­bet reverse, 5′­TC 
AACCAGCACCAGACAGAG­3′; CRTAM forward, 5′­TTAGAGTGAGC 
GTTTGGC CT­3′, and CRTAM reverse, 5′­GGGAGTCCTCAGTTTGCT 
GT­3′; RORγt forward, 5′­CCGCTGAGAGGGCTTCAC­3′, and RORγt 
reverse, 5′­TGCAGGAGTAGGCCACATTACA­3′; L32 forward, 5′­GAAA 
CTGGCGGAAACCCA­3′, and L32 reverse, 5′­GGATCTGGCCCTT 
GAACCTT­3′; IL­23R forward, 5′­TTCAGATGGGCATGAATGTTT 
CT­3′, and IL23R reverse, 5′­CCAAATCCGAGCTGTTGTTCTAT­3′; IL17A­ 
forward, 5′­TGAGAGCTGCCCCTTCACTT­3′, and IL17A reverse, 5′­ACG 
CAGGTGCAGCCCA­3′; IL­22­forward, 5′­CAGGAGGTGGTACC 
TTTCCTGA­3′, and IL­22 reverse, 5′­ TCTGGTCGTCACCGCTGAT­3′; 
IL­2­forward, 5′­CCTGAGCAGGATGGAGAATTACA­3′, and IL­2 
reverse, 5′­TCCAGAACATGCCGCAGAG­3′; IL­4 forward, 5′­ACAGGAG 
AAGGGACGCCAT­3′, and IL­4 reverse, 5′­GAAGCCCTACAGACGAGC 
TCA­3′; IL­13 forward 5′­AGACCAGACTCCCCTGTGCA­3′, and IL­13 reverse, 
5′­TGGGTCCTGTAGATGGCATTG­3′; granzyme A forward 5′­ATTCCT 
GAAGGAGGCTGTGAA­3′, and granzyme A reverse, 5′­GCAGGAGTCC 
TTTCCACCAC­3′; granzyme B forward 5′­GCCCACAACATCAA 
AGAACAG­3′, and granzyme B reverse, 5′­AACCAGCCACATAGCACA 
CAT­3′; CD8α forward, 5′­ACTGCAAGGAAGCAAGTGGT­3′, and CD8α  
reverse, 5′­CACCGCTAAAGGCAGTTCTC­3′; and IFN­γ forward, 5′­ 
ATGAACGCTACACACTGCATC ­3′, and IFN­γ reverse, 5′­ CCATCCTTTT 
GCCAGTTCCTC ­3′.
CD107 mobilization assay. The degranulation activity of cytolytic cells was 
measured as described48. Polyclonal IELs were enriched through the use of 
anti­CD45 microbeads (Miltenyi Biotec) and were then activated for 4 h at 
37 °C and 5% CO2 in 96­well U­bottomed plates with plate­bound antibody 
to TCRβ (2 µg/ml; H57­597; BD Biosciences) in the presence of anti­CD107a 
(1D4B; BD Biosciences) and brefeldin A. OT­II IELs were cultured for 6 h 
at 37 °C and 5% CO2 in 96­well V­bottomed plates with antigen­presenting 
LB27.4 cells (mouse B cell lymphoma treated overnight with LPS) at a ratio of 
5:1, in the presence of the MHC class II–specific peptide OVA(323–339) or the 
MHC class I–specific OVA peptide SIINFEKL peptide plus anti­CD107 and 
brefeldin A. In some cases, sorted IELs were cultured for 3 d in the presence 
of recombinant mouse IL2 (BD Biosciences) and recombinant human IL­15 
(R&D Systems). After stimulation, the expression of CD107 and cytokines was 
assessed by flow cytometry.
In vitro cytotoxicity assay. T cells crosslinked with anti­TCRβ were cultured 
for 6 h at 37 °C and 5% CO2 with P815 mouse lymphoblast­like mastocytoma 
target cells, and cytotoxicity was measured with the CytoTox 96 Non­
Radioactive cytotoxicity assay kit (Promega). The percentage of cytotoxicity 
was calculated on the basis of the release of lactate dehydrogenase. In some 
cases, cultured IELs were used.
Statistical analysis. Comparisons between groups used the Student’s t test 
assuming two­tailed distributions unless otherwise stated, with an alpha value 
of 0.01–0.05. In some samples A nonparametric two­tailed Mann­Whitney test 
or analysis of variance (ANOVA) and Bonferroni post­test were used.
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45. Mucida, D. et al. Reciprocal TH17 and regulatory T cell differentiation mediated 
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